Men et al. [27] reported a reduced ratio of CD4+/CD8+ cells in the SLE group and speculated that changes in the CD4+/CD8+ ratio interfere with and disrupt cellular immunity and lead to SLE. The gene discussed is CD4; the disease is systemic lupus erythematosus.